CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Sale | −4,142 | $43.50 | $180K | 99,470 |
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Sale | −8,456 | $45.18 | $382K | 91,014 |
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Sale | −38,900 | $45.93 | $1.8M | 52,114 |
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Sale | −32,718 | $46.88 | $1.5M | 19,396 |
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Option exercise · Stock Option | −20,547 | 135,674 | ||
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Option exercise · Stock Option | −34,414 | 20,662 | ||
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Option exercise · Stock Option | −44,079 | 91,592 | ||
| 2025-11-11 | Levy Adam Scott CFO and Secretary | Option exercise · Stock Option | −6,613 | 4,888 | ||
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −12,806 | $41.64 | $533K | 818,499 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −8,862 | $42.31 | $375K | 809,637 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −4,000 | $43.50 | $174K | 805,637 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −29,207 | $45.20 | $1.3M | 776,430 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −112,275 | $45.83 | $5.1M | 664,155 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −32,850 | $46.89 | $1.5M | 631,305 |
| 2025-11-11 | Gold Alexander M Director | Option exercise | +15,000 | $10.20 | $153K | 15,000 |
| 2025-11-11 | Gold Alexander M Director | Sale | −10,000 | $42.43 | $424K | 5,000 |
| 2025-11-11 | Gold Alexander M Director | Sale | −5,000 | $47.08 | $235K | 0 |
| 2025-11-11 | Gold Alexander M Director | Option exercise · Stock Option | −15,000 | 17,900 | ||
| 2025-10-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −10,369 | $43.01 | $446K | 71,155 |
| 2025-10-13 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −7,366 | $41.90 | $309K | 120,257 |
Page 12 of 17 · 321 trades